Today in News History
On July 12, several notable moments in the history of News stand out. In 1489, Bahlul Lodi, sultan of Delhi passed away. In 1664, Stefano della Bella, Italian illustrator and engraver (born 1610) passed away. In 1730, Josiah Wedgwood, English potter, founded the Wedgwood Company (died 1795) was born. In 1909, Fritz Leonhardt, German engineer, designed Fernsehturm Stuttgart (died 1999) was born. In 1935, Satoshi Ōmura, Japanese biochemist and academic, Nobel Prize laureate was born. In 1951, Joan Bauer, American author was born. In 1952, Voja Antonić, Serbian computer scientist and journalist, designed the Galaksija computer was born. In 1956, Mel Harris, American actress was born. In 1997, Malala Yousafzai, Pakistani-English activist, Nobel Prize laureate was born. In 2001, Space Shuttle program: Space Shuttle Atlantis is launched on mission STS-104, carrying the Quest Joint Airlock to the International Space Station. Together, these milestones provide historical context for today's news news and ongoing narratives.
[Best Brand] Miracell secures FDA 510(k) clearance for stem cell processing system
![[Best Brand] Miracell secures FDA 510(k) clearance for stem cell processing system](https://wimg.heraldcorp.com/news/cms/2026/06/24/news-p.v1.20260623.5be91df146c14926a929466a795841fd_T1.png)
STEM CELL PROCESSING SYSTEM MIRACELL SMART M-CELL Stem cell technology firm Miracell has secured US Food and Drug Administration 510(k) clearance for its integrated cell-processing system, marking a significant milestone in the company's efforts to expand its presence in the global regenerative medicine market. The FDA granted 510(k) clearance in April for a system comprising the Smart M-Cell cell concentration device, the BSC blood kit and the BmSC bone marrow kit. The clearance followed a subs
Narrative Intelligence Brief
This article was published by The korea Herald News, a source frequently categorized with a center bias based in South Korea. Our narrative intelligence engine continuously monitors coverage from this outlet to track framing, bias, and rhetorical patterns. Our initial algorithmic scan of this specific piece did not flag high-confidence rhetorical techniques, suggesting a generally straightforward reporting style or neutral framing. By understanding the editorial perspective of The korea Herald News, readers can better contextualize the information presented and compare it across our broader media matrix to find the real narrative.
More from The korea Herald News
July 12, 2026
Cooling off along Seoul's waterways
July 12, 2026
Summer heat sends 200,000 to Gangwon beaches for weekend dip
July 12, 2026
Global IP productions fuel record growth in Korea's theater market
July 12, 2026
Hanwha Life Esports wins 2026 MSI title after marathon five-game final
July 12, 2026
New slice-of-life novel finds comfort in food and human connection
Analysis Methodology
This narrative analysis was generated using the CoDataLab Global Intelligence Engine. Our proprietary AI scans thousands of cross-border sources to identify sentiment patterns, framing techniques, and potential media bias. While AI provides the data-driven foundation, our objective is to empower readers with additional context beyond the standard headline.The content displayed above is a structured summary designed for rapid information processing. For the full original report, please visit the source outlet.More Coverage
Discussion
"lindsey graham"
Kash Patel stuns with weird response to Lindsey Graham's death: 'Why is the FBI involved?'
Lindsey Graham death and World Cup semis | Reuters World News
"No Conspiracy": Former Israeli Consul Dismisses Conspiracy Theories about Lindsey Graham's Death
How other outlets are covering this story
Compare narratives across 6 related reports from 6 sources. Real Narrative News aggregates the coverage spectrum so you can see who emphasises what — bias tags reflect the outlet, not the story.
Coverage bias distribution
6 sources
Left 33%
Center 67%
Right 0%
The korea Herald News
· Jun 24, 2026
[Best Brand] Miracell wins FDA clearance for stem cell processing system
STEM CELL PROCESSING SYSTEM MIRACELL SMART M-CELL Stem cell technology firm Miracell has secured clearance from the US Food and Drug Administration for its integrated cell-processing system, marking a significant milestone in the company's efforts to expand its presence in the global regenerative medicine market. The FDA approved the system comprising the Smart M-Cell cell concentration device, the BSC blood kit and the BmSC bone marrow kit in April. This FDA clearance comes as Smart M-Cell demo
Korea Times News
· Jul 1, 2026
Celltrion secures FDA’s 1st interchangeable status for Rituximab biosimilar
Celltrion secures FDA’s 1st interchangeable status for Rituximab biosimilar
The Eastern Herald
· Jul 5, 2026
FDA Clears a Transplant Therapy Built to Cut Chronic GVHD From 44% to 13%
The FDA approved Tregzi, Orca Bio's engineered cell therapy, after a 187-patient trial found it cut moderate-to-severe chronic graft-versus-host disease from 44 with standard transplants to 13. The tradeoff patients now face is a newer therapy without years of follow-up data behind it.
CNBC
· Jun 29, 2026
Eli Lilly, Regeneron among first companies selected for FDA initiative to speed review of new manufacturing facilities
Eli Lilly and Regeneron are among the first seven companies the FDA has selected for its PreCheck Pilot Program, CNBC has learned.
CNET
· Jul 10, 2026
The Best Whitening Toothpastes Dentists Recommend to Their Patients
For removing stains and keeping your pearly whites bright, these are the best dentist-approved whitening toothpastes.
Investing.com
· Jun 29, 2026
Form 4 Celldex Therapeutics Inc For: 29 June
Form 4 Celldex Therapeutics Inc For: 29 June
Topics:
Related coverage for "[Best Brand] Miracell secures FDA 510(k) clearance for stem cell processing system": The korea Herald News — [Best Brand] Miracell wins FDA clearance for stem cell processing system. Korea Times News — Celltrion secures FDA’s 1st interchangeable status for Rituximab biosimilar. The Eastern Herald — FDA Clears a Transplant Therapy Built to Cut Chronic GVHD From 44% to 13%. CNBC — Eli Lilly, Regeneron among first companies selected for FDA initiative to speed review of new manufacturing facilities. CNET — The Best Whitening Toothpastes Dentists Recommend to Their Patients. Investing.com — Form 4 Celldex Therapeutics Inc For: 29 June